Karen S Lynch
CIK 1333760 · View on SEC EDGAR ↗
First SEC filing: May 22, 2026 · Latest: May 22, 2026
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 3, 2023 | CVS | P | 14,000 | $69.75 | $976,500 | 431,392 Direct | +3.35% | Acquired | 34.2% (price as of 2026-08-21) |
| Nov. 18, 2019 | CVS | S 10b5-1 | 80,143 | $75.00 | $6,010,725 | 41,831 Direct | -65.70% | Disposed | 24.8% (price as of 2026-08-21) |
| Sept. 18, 2017 | 1122304 | S | 15,271 | $161.91 | $2,472,528 | 64,261 Direct | -19.20% | Disposed | |
| June 7, 2017 | 1122304 | S | 7,825 | $149.72 | $1,171,559 | 64,261 Direct | -10.86% | Disposed | |
| Nov. 11, 2016 | 1122304 | S | 45,000 | $119.55 | $5,379,750 | 51,254 Direct | -46.75% | Disposed |
Showing latest 100 of 165 transactions
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 27, 2026 | TMO | Phantom Stock Units | Common Stock (61) | — | — | 61 | Acquired |
| March 28, 2026 | TMO | Phantom Stock Units | Common Stock (66) | — | — | 66 | Acquired |
| Dec. 31, 2025 | TMO | Phantom Stock Units | Common Stock (54) | — | — | 54 | Acquired |
| Sept. 27, 2025 | TMO | Phantom Stock Units | Common Stock (67) | — | — | 67 | Acquired |
| June 28, 2025 | TMO | Phantom Stock Units | Common Stock (77) | — | — | 77 | Acquired |
| March 29, 2025 | TMO | Phantom Stock Units | Common Stock (28) | — | — | 28 | Acquired |
| April 1, 2024 | CVS | Stock Option | Common Stock (188,087) | $79.56 | April 1, 2034 | 188,087 | Acquired |
| April 1, 2023 | CVS | Stock Option [F9] | Common Stock (244,952) | $74.31 | April 1, 2033 | 244,952 | Acquired |
| April 1, 2022 | CVS | Stock Option | Common Stock (171,517) | $101.09 | April 1, 2032 | 171,517 | Acquired |
| Dec. 17, 2021 | USB | Deferred Compensation Plan Participation | Common Stock, $0.01 par value (13) | — | — | 13 | Acquired |
| April 26, 2021 | USB | Deferred Compensation Plan Participation | Common Stock, $0.01 par value (1,211) | — | — | 1,211 | Acquired |
| April 22, 2021 | USB | Restricted Stock Units | Common Stock, $0.01 par value (2,849) | — | — | 2,849 | Acquired |
| April 1, 2021 | CVS | Stock Option | Common Stock (224,604) | $74.30 | April 1, 2031 | 224,604 | Acquired |
| Dec. 23, 2020 | USB | Deferred Compensation Plan Participation | Common Stock, $0.01 par value (33) | — | — | 33 | Acquired |
| April 24, 2020 | USB | Deferred Compensation Plan Participation | Common Stock, $0.01 par value (2,098) | — | — | 2,098 | Acquired |
| April 24, 2020 | USB | Restricted Stock Units | Common Stock, $0.01 par value (3,196) | — | — | 3,196 | Acquired |
| April 1, 2020 | CVS | Stock Option | Common Stock (211,196) | — | April 1, 2030 | 211,196 | Acquired |
| April 1, 2020 | CVS | Stock Option | Common Stock (211,196) | — | April 1, 2030 | 211,196 | Acquired |
| Dec. 27, 2019 | USB | Deferred Compensation Plan Participation | Common Stock, $0.01 par value (62) | — | — | 62 | Acquired |
| April 18, 2019 | USB | Deferred Compensation Plan Participation | Common Stock, $0.01 par value (1,123) | — | — | 1,123 | Acquired |
| April 18, 2019 | USB | Restricted Stock Units | Common Stock, $0.01 par value (3,124) | — | — | 3,124 | Acquired |
| April 1, 2019 | CVS | Stock Option | Common Stock (242,408) | $54.19 | April 1, 2029 | 242,408 | Acquired |
| Dec. 27, 2018 | USB | Deferred Compensation Plan Participation | Common Stock, $0.01 par value (132) | — | — | 132 | Acquired |
| Nov. 28, 2018 | CVS | Stock Appreciation Rights | Common Stock (192,741) | $45.91 | Feb. 16, 2027 | 192,741 | Acquired |
| Nov. 28, 2018 | CVS | Stock Appreciation Rights | Common Stock (93,989) | $37.91 | Feb. 18, 2026 | 93,989 | Acquired |
| Nov. 28, 2018 | 1122304 | Restricted Stock Units | Common Stock (30,981) | — | — | 30,981 | Disposed |
| Nov. 28, 2018 | 1122304 | Performance Stock Units | Common Stock (13,172) | — | — | 13,172 | Disposed |
| Nov. 28, 2018 | 1122304 | Performance Stock Units | Common Stock (29,580) | — | — | 29,580 | Disposed |
| Nov. 28, 2018 | 1122304 | Stock Appreciation Rights | Common Stock (105,941) | $125.27 | — | 105,941 | Disposed |
| Nov. 28, 2018 | 1122304 | Stock Appreciation Rights | Common Stock (103,323) | $103.45 | — | 103,323 | Disposed |
| Nov. 28, 2018 | 1122304 | Stock Appreciation Rights | Common Stock (110,209) | $100.50 | — | 110,209 | Disposed |
| April 20, 2018 | USB | Deferred Compensation Plan Participation | Common Stock, $0.01 par value (2,012) | — | — | 2,012 | Acquired |
| April 19, 2018 | USB | Restricted Stock Units | Common Stock, $0.01 par value (2,959) | — | — | 2,959 | Acquired |
| March 2, 2018 | 1122304 | Restricted Stock Units | Common Stock (30,981) | — | — | 30,981 | Acquired |
| March 2, 2018 | 1122304 | Performance Stock Units | Common Stock (14,926) | — | — | 14,926 | Disposed |
| Jan. 26, 2018 | USB | Deferred Compensation Plan Participation | Common Stock, $0.01 par value (561) | — | — | 561 | Acquired |
| Jan. 18, 2018 | USB | Restricted Stock Units | Common Stock, $0.01 par value (890) | — | — | 890 | Acquired |
| Dec. 19, 2017 | 1122304 | Performance Stock Units | Common Stock (14,926) | — | — | 14,926 | Acquired |
| Sept. 12, 2017 | 1122304 | Stock Appreciation Rights | Common Stock (53,773) | $72.26 | March 2, 2024 | 53,773 | Disposed |
| June 2, 2017 | 1122304 | Stock Appreciation Rights | Common Stock (30,000) | $72.26 | March 2, 2024 | 30,000 | Disposed |
| March 3, 2017 | 1122304 | Performance Stock Units | Common Stock (11,418) | — | — | 11,418 | Disposed |
| Feb. 17, 2017 | 1122304 | Stock Appreciation Rights | Common Stock (105,941) | $125.27 | Feb. 17, 2027 | 105,941 | Acquired |
| Jan. 19, 2017 | USB | Restricted Stock Units | Common Stock, $0.01 par value (2,957) | — | — | 2,957 | Acquired |
| Feb. 19, 2016 | 1122304 | Stock Appreciation Rights | Common Stock (103,323) | $103.45 | — | 103,323 | Acquired |
| Feb. 1, 2016 | 1122304 | Market Stock Units | Common Stock (27,000) | — | — | 27,000 | Disposed |
| Jan. 28, 2016 | 1122304 | Performance Stock Units | Common Stock (11,418) | — | — | 11,418 | Acquired |
| Jan. 19, 2016 | USB | Restricted Stock Units | Common Stock, $0.01 par value (3,876) | — | — | 3,876 | Acquired |
| July 23, 2015 | 1122304 | Market Stock Units | Common Stock (15,304) | — | — | 15,304 | Disposed |
| July 23, 2015 | 1122304 | Restricted Stock Units | Common Stock (17,902) | — | — | 17,902 | Disposed |
| March 2, 2015 | 1122304 | Stock Appreciation Right [F1] | Common Stock (110,209) | $100.50 | March 1, 2025 | 110,209 | Acquired |
| March 2, 2015 | 1122304 | Stock Appreciation Right | Common Stock (123,067) | $100.50 | March 1, 2025 | 123,067 | Acquired |
| Feb. 2, 2015 | 1122304 | Performance Stock Units | Common Stock (11,758) | — | — | 11,758 | Disposed |
| Jan. 15, 2015 | 1122304 | Performance Stock Units | Common Stock (5,879) | — | — | 5,879 | Acquired |
| July 23, 2014 | 1122304 | Performance Stock Units | Common Stock (13,696) | — | — | 13,696 | Disposed |
| July 23, 2014 | 1122304 | Market Stock Units | Common Stock (15,467) | — | — | 15,467 | Disposed |
| July 23, 2014 | 1122304 | Restricted Stock Units | Common Stock (17,902) | — | — | 17,902 | Disposed |
| March 3, 2014 | 1122304 | Stock Appreciation Right | Common Stock (83,773) | $72.26 | March 3, 2024 | 83,773 | Acquired |
| Jan. 29, 2014 | 1122304 | Performance Stock Units | Common Stock (5,879) | — | — | 5,879 | Acquired |
| Jan. 29, 2014 | 1122304 | Performance Stock Units | Common Stock (6,848) | — | — | 6,848 | Acquired |
| July 23, 2013 | 1122304 | Restricted Stock Units | Common Stock (17,902) | — | — | 17,902 | Disposed |
| Feb. 1, 2013 | 1122304 | Market Stock Units | Common Stock (27,000) | — | — | 27,000 | Acquired |
| Jan. 17, 2013 | 1122304 | Performance Stock Units | Common Stock (6,848) | — | — | 6,848 | Acquired |
| July 23, 2012 | 1122304 | Restricted Stock Unit | Common Stock (53,706) | — | — | 53,706 | Acquired |
| July 23, 2012 | 1122304 | Market Stock Unit | Common Stock (15,304) | — | — | 15,304 | Acquired |
| July 23, 2012 | 1122304 | Market Stock Unit | Common Stock (15,467) | — | — | 15,467 | Acquired |
| March 4, 2009 | 701221 | Employee Stock Option (Right to Buy) | Common Stock, $.25 Par Value (38,528) | $14.02 | March 4, 2019 | 38,528 | Acquired |
| Feb. 27, 2008 | 701221 | Employee Stock Option (Right to Buy) | Common Stock, $.25 Par Value (25,685) | $47.92 | Feb. 27, 2018 | 25,685 | Acquired |
| June 1, 2007 | 701221 | Employee Stock Option (Right to Buy) | Common Stock, $.25 Par Value (4,540) | $94.24 | Feb. 27, 2012 | 4,540 | Disposed |
| June 1, 2007 | 701221 | Employee Stock Option (Right to Buy) | Common Stock, $.25 Par Value (1,911) | $89.42 | Feb. 24, 2015 | 1,911 | Disposed |
| March 16, 2007 | 701221 | Employee Stock Option (Right to Buy) | Common Stock, $.25 Par Value (2,707) | $55.44 | Feb. 25, 2014 | 2,707 | Disposed |
| Feb. 28, 2007 | 701221 | Employee Stock Option (Right to Buy) | Common Stock, $.25 Par Value (6,762) | $140.65 | Feb. 28, 2017 | 6,762 | Acquired |
| Feb. 16, 2007 | 701221 | Employee Stock Option (Right to Buy) | Common Stock, $.25 Par Value (3,333) | $41.09 | July 23, 2013 | 3,333 | Disposed |
| March 2, 2006 | 701221 | Employee Stock Option (Right to Buy) | Common Stock, $.25 Par Value (3,010) | $41.92 | Feb. 26, 2013 | 3,010 | Disposed |
| March 2, 2006 | 701221 | Employee Stock Option (Right to Buy) | Common Stock, $.25 Par Value (2,708) | $55.44 | Feb. 25, 2014 | 2,708 | Disposed |
| March 2, 2006 | 701221 | Employee Stock Option (Right to Buy) | Common Stock, $.25 Par Value (1,913) | $89.42 | Feb. 24, 2015 | 1,913 | Disposed |
| Feb. 22, 2006 | 701221 | Employee Stock Option (Right to Buy) | Common Stock, $.25 Par Value (6,385) | $121.70 | Feb. 22, 2016 | 6,385 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
CVS
CEO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $1,191,781 | — | — | — | $2,383,562 | — | $1,856,281 | $23,431,466 |
| 2023 | $1,500,000 | — | $12,374,971 | $4,124,992 | $2,992,000 | — | $623,071 | $21,615,034 |
| 2022 | $1,487,500 | — | $12,374,946 | $4,124,984 | $2,975,000 | — | $354,625 | $21,317,055 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.